Repurposing screen identifies novel candidates for broad-spectrum coronavirus antivirals and druggable host targets.

Journal Information

Full Title: Antimicrob Agents Chemother

Abbreviation: Antimicrob Agents Chemother

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anti-Infective Agents

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"table s1 aac 01210-23-s0002 xlsx"

Code Sharing
Evidence found in paper:

"The authors declare no conflict of interest."

Evidence found in paper:

"We are grateful for the gift of the SARS-CoV-2/München-1.2/2020/984 strain by Christian Drosten and to Volker Thiel for sharing the HCoV-229E/R-Luc reporter virus. This publication was supported by the European Virus Archive GLOBAL (EVA-GLOBAL) project that has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No. 871029. We thank Charles M. Rice for the gift of Huh-7.5 cells, Gert Zimmer for 16HBE140, and Volker Thiel for MRC-5 cells. We also gratefully acknowledge the gifts of Vero and Calu-3 cells by Stefan Pöhlmann and the provision of the TCID50-calculator by Marco Binder. We thank Novartis, specifically Stefan Peukert, for providing AXT-914, and Anne Kühnel, Christina Grethe, and Xiaoyu Zhang for their technical support, as well as Sonja Jesse for her contribution to the introduction section. We also thank Chris Lauber for generating the graph in Fig. 3A. Funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – Projektnummer 158989968 - SFB 900. T.P., T.F.S, M.B., and U.B received funding from the Niedersächsisches Ministerium für Wissenschaft und Kultur (Ministry for Science and Culture of Lower Saxony) (grant 14–76103-184 CORONA-13/20). T.P. and T.F.S. received funding from the German Center of Infection Research (DZIF). T.P. also received funding from the Helmholtz Alberta initiative for infectious disease research (HAI-IDR) and from the DFG CRC900 project A6 (project number: 158989968; https://gepris.dfg.de/gepris/projekt/178926377). G.V. received funding from the Deutsche Forschungsgemeinschaft (project number 417852234). G.G. received funding from the Knut and Alice Wallenberg Foundation, the Federal Ministry of Education and Research (BMBF) project COVID-Protect (# 01KI20143C), and the Niedersächsisches Ministerium für Wissenschaft und Kultur (Ministry for Science and Culture of Lower Saxony) and “Niedersachsen Vorab” through the Professorinnen Programm III. G.B. and G.G. received funding from the Ministry of Lower Saxony (MWK, Project 76251–99 awarded to G.G.). Conceptualization: S.H. and T.P. Methodology: S.H., A.M., M.W., A.P.G., S.M.S., L.L., F.Z.B., G.B., G.G., V.M., and M.G. Validation: S.H., A.M., M.W., J.R., and A.P.G. Formal analysis: S.H., A.M., M.W., S.M.S., A.P.G., D.K., G.V., M.G., R.J.P.B., and N.M.K. Investigation: S.H., A.M., M.W., J.R., A.P.G., L.L., F.Z.B., G.B., M.G., and N.M.K. Resources: B.W., T.T.N., U.B., and T.F.S. Data curation: S.H., A.M., M.W., S.M.S., A.P.G., and R.B. Writing—original draft: S.H., A.M., M.W., A.P.G., G.V., M.B., and T.P. Writing—review & editing: S.H., A.M., M.W., S.M.S., M.B., A.P.G., L.L., D.K., G.V., B.W., F.Z.B., G.B., G.G., U.B., V.M., M.G., and R.J.P.B. Visualization: S.H., A.M., M.W., S.M.S., D.K., and T.P. Supervision: G.V., G.G., T.F.S., and T.P. Project administration: S.H., M.B., and T.P. Funding acquisition: M.B., T.F.S., T.P., G.V., G.G., and U.B."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025